Browsing Category
Medicines for Covid-19
19 posts
5 Bold Predictions for Long COVID Treatment in 2024: Latest Research Insights
thehealthtransformation.foundation Joaquim Cardoso MSc February 1, 2024 This executive summary is based on the article “Five Bold Predictions for…
Simnotrelvir: Novo Comprimido Contra a COVID-19 Oferece Alívio Rápido – Sucesso Clínico, Custo Reduzido e Aplicação Mais Ampla
The health strategist institute, portal & consultingfor workforce health & economic prosperity Joaquim Cardoso MSc. Servant Leader, Chief Research…
Simnotrelvir: Breakthrough COVID Pill Offers Swift Relief – Clinical Success, Lower Cost, and Wider Applicability
the health strategist institute, portal & consultingfor workforce health & economic prosperity Joaquim Cardoso MSc. Servant Leader, Chief Research…
A nasal spray protects against coronavirus infection — Effective also against recent immune-evasive variants
the health strategist research and strategy institute for continuous transformationin value based health, care and tech Joaquim Cardoso…
Early Treatment with Pegylated Interferon Lambda for Covid-19 — [a “new” old drug (interferon) for the covid arsenal]
health and techinstitute Joaquim Cardoso MScFounder, Chief Researcher & EditorFebruary 9, 2023 ABSTRACT BACKGROUND METHODS RESULTS CONCLUSIONS (Funded by…
COVID drug Paxlovid was hailed as a game-changer. What happened? Which competition is coming?
the health strategist institute for continuous health transformation& digital health Joaquim Cardoso MScChief Researcher, Editor and Senior AdvisorJanuary…
A Valuable COVID Drug Doesn’t Work against New Variants [ bebtelovimab]
health transformationstrategy institute Joaquim Cardoso MScChief Researcher, Editor and Senior AdvisorJanuary3, 2023 Executive Summary [by the Editor of…
V116 Promising new Covid pill shows advantages over Paxlovid in trial [with 822 participants]
A Chinese antiviral pill was found to be as effective as Paxlovid in a Phase 3 trial, and…
Antiviral treatments lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patients [excerpt]
transforming health institute for continuous health transformation& digital health Joaquim Cardoso MScFounder and Chief Researcher & EditorDecember 25, 2022…
Merck antiviral trial shows promising impact on Covid recovery time – [though it did not prevent it ]
This is a republication of the article “Merck antiviral trial shows promising impact on Covid recovery time”, with…